AKT1 and esophageal cancer: To reveal the specific mechanism of the PI3K/Akt signaling pathway in the occurrence and development of EC, in this study, human esophageal cancer cell line Eca109 was cultured in vitro, and the cells were treated with PI3K/Akt signaling pathway inhibitor afuresertib to observe cell survival, proliferation, and apoptosis.